3Hathoway WE, Gthens JA, Blaekburn JR, et al. Aplastic anemia,histiocytosis, and erythroderma in immunologically deficient children[J]. N Engl J Med, 1995,273:953-955.
4Moroff G, Luban N. The irradiation of blood and blood components to prevent graft - versus - host disease [J]. Transt Med Rev, 1997,11:15.
5Przepiorka D, Leprac GF, Stovall MA, et al. Use of irradiated blood components practice parameter[J]. Am J Clin pathol, 1996,106(1):6-11.
6Tasaki T, Ohio H, Abe R. Prevention of post transfusion graft versus host disease[J]. Fukushima J Med sci, 1993,39 (2):109-111.
7Gelly KJ, kerr R, Rawlinsons, et al. Transfusion -associated graft versus host disease in a potient with high - grade B-cell lymphoma[J]. Br J Haematol,2000, 110(1):228-229.
8Takahashi K. Post - transfusion graft - versus - host disease occurring in nonimmuno suppressed patients in Japan [J]. Transfusion Sci,1991,12(3):281.
9Tanei R, Ohta Y, Ishihara S, et al. Transfusion - associates graft -versus- host disease:an in situ hybridization analysis of the infiltrating donnrderived cells in the cutaneous lesion [J]. Dermatology,1999,199:20-24.
10Warrer LJ, Simmerk, Roxby D, et al. DNA polymorphism analysis in vransfusion - associated graft - versus - host disease [J]. J Paediatr Chiht Health, 1999,35:98-101.
